您的购物车当前为空
别名 达拉地, SB-480848
Darapladib (SB-480848) 是脂蛋白相关磷脂酶A2 (Lp-PLA2) 抑制剂,IC50值为0.25 nM,可发挥心血管保护作用[1,3]。


为众多的药物研发团队赋能,
让新药发现更简单!
Darapladib (SB-480848) 是脂蛋白相关磷脂酶A2 (Lp-PLA2) 抑制剂,IC50值为0.25 nM,可发挥心血管保护作用[1,3]。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 352 | In Stock | |
| 2 mg | ¥ 513 | In Stock | |
| 5 mg | ¥ 853 | In Stock | |
| 10 mg | ¥ 1,430 | In Stock | |
| 25 mg | ¥ 2,970 | In Stock | |
| 50 mg | ¥ 4,200 | In Stock | |
| 100 mg | ¥ 6,130 | In Stock | |
| 200 mg | ¥ 8,260 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 960 | In Stock |
Darapladib 相关产品
| 产品描述 | Darapladib (SB-480848) is a lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with an IC50 value of 0.25 nM, which can exert cardiovascular protective effects [1,3]. |
| 靶点活性 | Lp-PLA2:0.25 nM |
| 体外活性 | 方法:骨髓源性巨噬细胞 (BMDM)用LPS(100ng/mL)引发3小时,然后用100 nM的Darapladib (SB-480848)处理1小时,然后在指定时间内进行Ang II(100 nmol/L)处理。 |
| 体内活性 | 方法:动脉粥样硬化Sprague-Dawley 大鼠喂食高胆固醇饮食 10 周,然后在 2 周内口服低剂量Darapladib (SB-480848) (25 mg·kg-1·d-1) 和高剂量达Darapladib (SB-480848) (50 mg·kg-1·d-1) 干预。 |
| 别名 | 达拉地, SB-480848 |
| 分子量 | 666.77 |
| 分子式 | C36H38F4N4O2S |
| CAS No. | 356057-34-6 |
| Smiles | C(C(N(CC1=CC=C(C=C1)C2=CC=C(C(F)(F)F)C=C2)CCN(CC)CC)=O)N3C4=C(C(=O)N=C3SCC5=CC=C(F)C=C5)CCC4 |
| 密度 | 1.259g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 123.75 mg/mL (185.6 mM), Sonication is recommended. Ethanol: 93 mg/mL (139.48 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (6 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容